Nordics - Revision history

Admin 3julmthh: Added from research

2026-04-13T19:01:38Z

Added from research

@@ Line 58: / Line 58: @@
 |-
 | [[BOOST Pharma]] || Cell Therapy || EUR 3.1M+ || RoslinCT partnership
 |}
@@ Line 72: / Line 92: @@
 * [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]
 * [[Knowledge Graphs in Health]] — [[AIDAVA]] and related projects
 == Ecosystem Notes ==
-Sweden significantly ahead in funding and unicorns. Norway more device/RPM focused. Actithera's $75.5M is largest Norwegian health raise. a16z entering Nordics via [[Dentio]].
+Sweden significantly ahead in funding and unicorns. Norway more device/RPM focused. Denmark emerging with [[VentriJect]] and [[Hemi Health]]. Finland growing via Maria 01 campus with 3x funding growth in 2025. Actithera's $75.5M is largest Norwegian health raise. a16z entering Nordics via [[Dentio]]. Novo Nordisk Foundation granted DKK 5.5B for innovation.
 [[Category:Region]]

Admin 3julmthh: New page

2026-04-13T18:05:06Z

New page

← Older revision		Revision as of 18:05, 13 April 2026
Line 1:		Line 1:
	__NOTOC__		__NOTOC__

	Norway, Sweden, Denmark, Finland — digital health hub.		Norway, Sweden, Denmark, Finland — digital health hub.

	== Norway 🇳🇴 ==		== Norway ==
	{\|		{\| class="wikitable"
	\|-		\|-
	! Company !! Category !! Funding !! Status		! Company !! Category !! Funding !! Status
	\|-		\|-
	\| [[Noteless]] \|\| AI Clinical Documentation \|\| €3.5M Seed \|\| Active, 3,000+ clinicians		\| [[Noteless]] \|\| AI Clinical Documentation \|\| EUR 3.5M Seed \|\| Active, 3,000+ clinicians
	\|-		\|-
	\| [[Dr. Dropin]] \|\| Digi-Physical Healthcare \|\| ~~€19~~.2M \|\| Expanding to London		\| [[Dr. Dropin]] \|\| Digi-Physical Healthcare \|\| EUR 19.2M \|\| Expanding to London
	\|-		\|-
	\| [[Nolla Health]] \|\| AI Dermatology \|\| $4.5M \|\| Launched in US		\| [[Nolla Health]] \|\| AI Dermatology \|\| $4.5M \|\| Launched in US
	\|-		\|-
	\| [[Actithera]] \|\| Radiopharma ~~/ Radioligand Therapy~~ \|\| $75.5M Series A \|\| Pipeline development		\| [[Actithera]] \|\| Radiopharma \|\| $75.5M Series A \|\| Pipeline development
	\|-		\|-
	\| [[Dignio]] \|\| Remote Patient Monitoring \|\| Acquired by [[Summa Equity]] \|\| NHS pilot in UK		\| [[Dignio]] \|\| Remote Patient Monitoring \|\| Acquired by [[Summa Equity]] \|\| NHS pilot in UK
Line 20:		Line 19:
	\| [[Holberg EEG]] \|\| AI Neurodiagnostics \|\| Acquired by Natus \|\| Global autoSCORE launch		\| [[Holberg EEG]] \|\| AI Neurodiagnostics \|\| Acquired by Natus \|\| Global autoSCORE launch
	\|-		\|-
	\| [[Lioness Medtech]] \|\| Portable MRI ~~/ Brain Imaging~~ \|\| ~~N/A (partnership)~~ \|\| First portable MRI in Norway		\| [[Lioness Medtech]] \|\| Portable MRI \|\| Partnership \|\| First portable MRI in Norway
	\|-		\|-
	\| [[No Isolation]] \|\| Social Impact Robots \|\| Undisclosed \|\| Deployed in UK+		\| [[No Isolation]] \|\| Social Impact Robots \|\| Undisclosed \|\| Deployed in UK+
Line 27:		Line 26:
	\|}		\|}

	== Sweden 🇸🇪 ==		== Sweden ==
	{\|		{\| class="wikitable"
	\|-		\|-
	! Company !! Category !! Funding !! Status		! Company !! Category !! Funding !! Status
	\|-		\|-
	\| [[Neko Health]] \|\| Preventive Health / AI Scanning \|\| $260M ($1.8B val) \|\| ~~Clinics in~~ Stockholm, London, NYC ~~planned~~		\| [[Neko Health]] \|\| Preventive Health / AI Scanning \|\| $260M ($1.8B val) \|\| Stockholm, London, NYC
	\|-		\|-
	\| [[Tandem Health]] \|\| AI Clinical OS \|\| ~~€42~~.6M Series A \|\| 200K+ NHS staff, 5 EU markets		\| [[Tandem Health]] \|\| AI Clinical OS \|\| EUR 42.6M Series A \|\| 200K+ NHS staff, 5 EU markets
	\|-		\|-
	\| [[Kry / Livi]] \|\| Telehealth \|\| $316M+ (~$2B val) \|\| Profitable, 5 countries		\| [[Kry / Livi]] \|\| Telehealth \|\| $316M+ (~$2B val) \|\| Profitable, 5 countries
Line 40:		Line 39:
	\| [[Mindler]] \|\| Digital Mental Health \|\| $8.7M \|\| Acquired ieso UK, Medified FI		\| [[Mindler]] \|\| Digital Mental Health \|\| $8.7M \|\| Acquired ieso UK, Medified FI
	\|-		\|-
	\| [[Acorai]] \|\| Cardiac Monitoring \|\| €4.2M+ \|\| FDA Breakthrough Device ~~designation~~		\| [[Acorai]] \|\| Cardiac Monitoring \|\| EUR 4.2M+ \|\| FDA Breakthrough Device
	\|-		\|-
	\| [[Dentio]] \|\| AI Dental \|\| $2.3M (a16z) \|\| Early stage		\| [[Dentio]] \|\| AI Dental \|\| $2.3M (a16z) \|\| Early stage
	\|-		\|-
	\| [[Cellcolabs]] \|\| Stem Cell ~~Manufacturing~~ \|\| $12M \|\| Bryan Johnson-backed		\| [[Cellcolabs]] \|\| Stem Cell Mfg \|\| $12M \|\| Bryan Johnson-backed
	\|-		\|-
	\| [[Meela]] \|\| Patient-Therapist ~~Matching~~ \|\| €2.6M Seed \|\| Gothenburg~~-based~~		\| [[Meela]] \|\| Patient-Therapist Match \|\| EUR 2.6M Seed \|\| Gothenburg
	\|-		\|-
	\| [[Sakura]] \|\| B2B Mental Health \|\| Pre-seed \|\| Female-founded		\| [[Sakura]] \|\| B2B Mental Health \|\| Pre-seed \|\| Female-founded
	\|-		\|-
	\| [[TrialMe]] \|\| Femtech / Clinical Trials \|\| Undisclosed \|\| ~~Fixing gender~~ gap in trials		\| [[TrialMe]] \|\| Femtech / Clinical Trials \|\| Undisclosed \|\| Gender gap in trials
	\|-		\|-
	\| [[Loovi]] \|\| Preventive Health \|\| ~~€1M~~ \|\| Early stage		\| [[Loovi]] \|\| Preventive Health \|\| EUR 1M \|\| Early stage
	\|-		\|-
	\| [[Doctrin]] \|\| Digital Primary Care \|\| Undisclosed \|\| New CEO, UK expansion		\| [[Doctrin]] \|\| Digital Primary Care \|\| Undisclosed \|\| New CEO, UK expansion
	\|-		\|-
	\| [[Min Doktor]] \|\| Online Healthcare \|\| €4.7M \|\| Struggling to scale		\| [[Min Doktor]] \|\| Online Healthcare \|\| EUR 4.7M \|\| Struggling to scale
	\|-		\|-
	\| [[BOOST Pharma]] \|\| Cell Therapy \|\| €3.1M+ \|\| RoslinCT partnership		\| [[BOOST Pharma]] \|\| Cell Therapy \|\| EUR 3.1M+ \|\| RoslinCT partnership
	\|}		\|}

	== ~~Key Investors~~ ==		== Funding & Support ==
	~~See~~ [[~~Investors~~]] ~~for the full list. Key names:~~ [[~~Kinnevik~~]], [[~~Northzone~~]], ~~[[Alliance VC]]~~, [[~~Summa Equity~~]], [[~~Novo Holdings~~]].		* [[Soft Funding Norway]] — Norwegian grants, tax credits, EU programs
			* [[Investors Norway Digital Health]] — Norwegian VCs and funds
			* [[Nordic Health Incubators]] — incubators, accelerators, university TTOs
			* [[Investors]] — full Nordic/EU investor list
			* [[Soft Funding]] — EU-wide soft funding

	== Key Topics ==		== Key Topics ==
	* [[Soft Funding]] — Norwegian and EU grant programs		* [[AI Clinical Documentation]] — [[Noteless]], [[Tandem Health]], [[Dentio]]
	* [[AI Clinical Documentation]] — ~~hottest subsector:~~ [[Noteless]], [[Tandem Health]], [[Dentio]]
	* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]		* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]
	* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]		* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]
	* [[~~Blood Tech~~]] — [[~~Actithera]], [[Acorai]], [[Cellcolabs]], [[BOOST Pharma~~]]		* [[Knowledge Graphs in Health]] — [[AIDAVA]] and related projects

	== Ecosystem Notes ==		== Ecosystem Notes ==
	Sweden significantly ahead ~~of Norway~~ in ~~digital health~~ funding and ~~unicorn creation~~. Norway more device/RPM focused~~; Sweden dominates AI-first health companies~~. Actithera's $75.5M ~~Series A (~~largest Norwegian health raise~~) shows radiopharma attracting big capital~~. a16z entering Nordics via [[Dentio]] ~~signals US VC interest~~.		Sweden significantly ahead in funding and unicorns. Norway more device/RPM focused. Actithera's $75.5M is largest Norwegian health raise. a16z entering Nordics via [[Dentio]].

	~~== Sources ==~~
	~~See [[Publications]] for all source publications.~~

	~~== See Also ==~~
	* [[:Category:Company]]
	* [[:Category:Norway]]
	* [[:Category:Sweden]]

	[[Category:Region]]		[[Category:Region]]

Admin 3julmthh: Fixed doubled title

2026-04-13T17:29:31Z

Fixed doubled title

← Older revision		Revision as of 17:29, 13 April 2026
Line 1:		Line 1:
	__NOTOC__		__NOTOC__
	~~= Nordics =~~

	Norway, Sweden, Denmark, Finland — digital health hub.		Norway, Sweden, Denmark, Finland — digital health hub.

Admin 3julmthh: Added new company

2026-04-13T16:06:48Z

Added new company

← Older revision		Revision as of 16:06, 13 April 2026
Line 14:		Line 14:
	\|-		\|-
	\| [[Nolla Health]] \|\| AI Dermatology \|\| $4.5M \|\| Launched in US		\| [[Nolla Health]] \|\| AI Dermatology \|\| $4.5M \|\| Launched in US
			\|-
			\| [[Actithera]] \|\| Radiopharma / Radioligand Therapy \|\| $75.5M Series A \|\| Pipeline development
	\|-		\|-
	\| [[Dignio]] \|\| Remote Patient Monitoring \|\| Acquired by [[Summa Equity]] \|\| NHS pilot in UK		\| [[Dignio]] \|\| Remote Patient Monitoring \|\| Acquired by [[Summa Equity]] \|\| NHS pilot in UK
	\|-		\|-
	\| [[Holberg EEG]] \|\| AI Neurodiagnostics \|\| Acquired by Natus \|\| Global autoSCORE launch		\| [[Holberg EEG]] \|\| AI Neurodiagnostics \|\| Acquired by Natus \|\| Global autoSCORE launch
			\|-
			\| [[Lioness Medtech]] \|\| Portable MRI / Brain Imaging \|\| N/A (partnership) \|\| First portable MRI in Norway
	\|-		\|-
	\| [[No Isolation]] \|\| Social Impact Robots \|\| Undisclosed \|\| Deployed in UK+		\| [[No Isolation]] \|\| Social Impact Robots \|\| Undisclosed \|\| Deployed in UK+
Line 36:		Line 40:
	\|-		\|-
	\| [[Mindler]] \|\| Digital Mental Health \|\| $8.7M \|\| Acquired ieso UK, Medified FI		\| [[Mindler]] \|\| Digital Mental Health \|\| $8.7M \|\| Acquired ieso UK, Medified FI
			\|-
			\| [[Acorai]] \|\| Cardiac Monitoring \|\| €4.2M+ \|\| FDA Breakthrough Device designation
	\|-		\|-
	\| [[Dentio]] \|\| AI Dental \|\| $2.3M (a16z) \|\| Early stage		\| [[Dentio]] \|\| AI Dental \|\| $2.3M (a16z) \|\| Early stage
	\|-		\|-
	\| [[Cellcolabs]] \|\| Stem Cell Manufacturing \|\| $12M \|\| Bryan Johnson-backed		\| [[Cellcolabs]] \|\| Stem Cell Manufacturing \|\| $12M \|\| Bryan Johnson-backed
			\|-
			\| [[Meela]] \|\| Patient-Therapist Matching \|\| €2.6M Seed \|\| Gothenburg-based
	\|-		\|-
	\| [[Sakura]] \|\| B2B Mental Health \|\| Pre-seed \|\| Female-founded		\| [[Sakura]] \|\| B2B Mental Health \|\| Pre-seed \|\| Female-founded
			\|-
			\| [[TrialMe]] \|\| Femtech / Clinical Trials \|\| Undisclosed \|\| Fixing gender gap in trials
	\|-		\|-
	\| [[Loovi]] \|\| Preventive Health \|\| €1M \|\| Early stage		\| [[Loovi]] \|\| Preventive Health \|\| €1M \|\| Early stage
Line 60:		Line 70:
	* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]		* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]
	* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]		* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]
			* [[Blood Tech]] — [[Actithera]], [[Acorai]], [[Cellcolabs]], [[BOOST Pharma]]

	== Ecosystem Notes ==		== Ecosystem Notes ==
	Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. a16z entering Nordics via [[Dentio]] signals US VC interest.		Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. Actithera's $75.5M Series A (largest Norwegian health raise) shows radiopharma attracting big capital. a16z entering Nordics via [[Dentio]] signals US VC interest.

			== Sources ==
			See [[Publications]] for all source publications.

	== See Also ==		== See Also ==
Line 68:		Line 82:
	* [[:Category:Norway]]		* [[:Category:Norway]]
	* [[:Category:Sweden]]		* [[:Category:Sweden]]
	* [[Publications]]

	[[Category:Region]]		[[Category:Region]]

Admin 3julmthh: Updated

2026-04-13T15:48:50Z

Updated

← Older revision		Revision as of 15:48, 13 April 2026
Line 5:		Line 5:

	== Norway 🇳🇴 ==		== Norway 🇳🇴 ==
	* [[Noteless]] — €3.5M, ~~AI clinical docs~~, ~~Oslo~~		{\|
	* [[Dr. Dropin]] — €19.2M~~, digi~~-~~physical healthcare, Oslo~~		\|-
	* [[Nolla Health]] — $4.5M~~, AI dermatology, now~~ US-~~focused~~		! Company !! Category !! Funding !! Status
	* '''Dignio~~''' — remote patient monitoring, acquired~~ by Summa Equity		\|-
	* '''Holberg EEG~~''' —~~ AI ~~neurodiagnostics, acquired~~ by Natus ~~Medical~~		\| [[Noteless]] \|\| AI Clinical Documentation \|\| €3.5M Seed \|\| Active, 3,000+ clinicians
	* '''No Isolation~~''' — social robots for isolated children~~		\|-
	* '''Journalia~~''' —~~ $1M~~, AI healthcare admin~~		\| [[Dr. Dropin]] \|\| Digi-Physical Healthcare \|\| €19.2M \|\| Expanding to London
			\|-
			\| [[Nolla Health]] \|\| AI Dermatology \|\| $4.5M \|\| Launched in US
			\|-
			\| [[Dignio]] \|\| Remote Patient Monitoring \|\| Acquired by [[Summa Equity]] \|\| NHS pilot in UK
			\|-
			\| [[Holberg EEG]] \|\| AI Neurodiagnostics \|\| Acquired by Natus \|\| Global autoSCORE launch
			\|-
			\| [[No Isolation]] \|\| Social Impact Robots \|\| Undisclosed \|\| Deployed in UK+
			\|-
			\| [[Journalia]] \|\| AI Healthcare Admin \|\| $1M \|\| Early stage
			\|}

	== Sweden 🇸🇪 ==		== Sweden 🇸🇪 ==
	* [[Neko Health]] — $260M, $1.8B ~~valuation~~, ~~AI body scanning~~		{\|
	* [[Tandem Health]] — €42.6M Series A, ~~AI clinical OS~~		\|-
	* [[Kry / Livi]] — $2B ~~valuation~~, ~~telehealth leader~~		! Company !! Category !! Funding !! Status
	* [[Mindler]] — $8.7M, ~~digital mental health~~		\|-
	* [[Dentio]] — $2.3M ~~from~~ a16z~~, AI dental~~		\| [[Neko Health]] \|\| Preventive Health / AI Scanning \|\| $260M ($1.8B val) \|\| Clinics in Stockholm, London, NYC planned
	* [[Cellcolabs]] — $12M~~, stem cell manufacturing~~		\|-
	* '''Sakura~~''' — pre~~-seed~~, B2B mental health~~		\| [[Tandem Health]] \|\| AI Clinical OS \|\| €42.6M Series A \|\| 200K+ NHS staff, 5 EU markets
	* '''Loovi~~''' —~~ €1M, ~~preventive health/longevity~~		\|-
	* '''Doctrin''' — digital primary care		\| [[Kry / Livi]] \|\| Telehealth \|\| $316M+ (~$2B val) \|\| Profitable, 5 countries
	* '''Min Doktor~~''' —~~ €4.7M~~, struggling~~ to scale		\|-
	* '''BOOST Pharma~~''' —~~ €3.1M~~, cell therapy for bone disease~~		\| [[Mindler]] \|\| Digital Mental Health \|\| $8.7M \|\| Acquired ieso UK, Medified FI
			\|-
			\| [[Dentio]] \|\| AI Dental \|\| $2.3M (a16z) \|\| Early stage
			\|-
			\| [[Cellcolabs]] \|\| Stem Cell Manufacturing \|\| $12M \|\| Bryan Johnson-backed
			\|-
			\| [[Sakura]] \|\| B2B Mental Health \|\| Pre-seed \|\| Female-founded
			\|-
			\| [[Loovi]] \|\| Preventive Health \|\| €1M \|\| Early stage
			\|-
			\| [[Doctrin]] \|\| Digital Primary Care \|\| Undisclosed \|\| New CEO, UK expansion
			\|-
			\| [[Min Doktor]] \|\| Online Healthcare \|\| €4.7M \|\| Struggling to scale
			\|-
			\| [[BOOST Pharma]] \|\| Cell Therapy \|\| €3.1M+ \|\| RoslinCT partnership
			\|}

	== Key Investors ==		== Key Investors ==
	* [[Investors]] — full list ~~of Nordic and European investors~~		See [[Investors]] for the full list. Key names: [[Kinnevik]], [[Northzone]], [[Alliance VC]], [[Summa Equity]], [[Novo Holdings]].

	== Key Topics ==		== Key Topics ==
	* [[Soft Funding]] — Norwegian and EU grant programs		* [[Soft Funding]] — Norwegian and EU grant programs
	* [[AI Clinical Documentation]] — hottest subsector (Noteless, Tandem, Dentio)		* [[AI Clinical Documentation]] — hottest subsector: [[Noteless]], [[Tandem Health]], [[Dentio]]
			* [[Telehealth]] — [[Kry / Livi]], [[Dr. Dropin]], [[Dignio]]
			* [[Preventive Health]] — [[Neko Health]], [[Loovi]], [[Cellcolabs]]

	== Ecosystem Notes ==		== Ecosystem Notes ==
	Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. a16z entering Nordics via Dentio signals US VC interest.		Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. a16z entering Nordics via [[Dentio]] signals US VC interest.

	== See Also ==		== See Also ==
Line 40:		Line 68:
	* [[:Category:Norway]]		* [[:Category:Norway]]
	* [[:Category:Sweden]]		* [[:Category:Sweden]]
			* [[Publications]]

	[[Category:Region]]		[[Category:Region]]

Admin 3julmthh: Restructured wiki

2026-04-13T15:35:35Z

Restructured wiki

New page

__NOTOC__
= Nordics =

Norway, Sweden, Denmark, Finland — digital health hub.

== Norway 🇳🇴 ==
* [[Noteless]] — €3.5M, AI clinical docs, Oslo
* [[Dr. Dropin]] — €19.2M, digi-physical healthcare, Oslo
* [[Nolla Health]] — $4.5M, AI dermatology, now US-focused
* '''Dignio''' — remote patient monitoring, acquired by Summa Equity
* '''Holberg EEG''' — AI neurodiagnostics, acquired by Natus Medical
* '''No Isolation''' — social robots for isolated children
* '''Journalia''' — $1M, AI healthcare admin

== Sweden 🇸🇪 ==
* [[Neko Health]] — $260M, $1.8B valuation, AI body scanning
* [[Tandem Health]] — €42.6M Series A, AI clinical OS
* [[Kry / Livi]] — $2B valuation, telehealth leader
* [[Mindler]] — $8.7M, digital mental health
* [[Dentio]] — $2.3M from a16z, AI dental
* [[Cellcolabs]] — $12M, stem cell manufacturing
* '''Sakura''' — pre-seed, B2B mental health
* '''Loovi''' — €1M, preventive health/longevity
* '''Doctrin''' — digital primary care
* '''Min Doktor''' — €4.7M, struggling to scale
* '''BOOST Pharma''' — €3.1M, cell therapy for bone disease

== Key Investors ==
* [[Investors]] — full list of Nordic and European investors

== Key Topics ==
* [[Soft Funding]] — Norwegian and EU grant programs
* [[AI Clinical Documentation]] — hottest subsector (Noteless, Tandem, Dentio)

== Ecosystem Notes ==
Sweden significantly ahead of Norway in digital health funding and unicorn creation. Norway more device/RPM focused; Sweden dominates AI-first health companies. a16z entering Nordics via Dentio signals US VC interest.

== See Also ==
* [[:Category:Company]]
* [[:Category:Norway]]
* [[:Category:Sweden]]

[[Category:Region]]